SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GNBT Generex -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (85)2/13/2006 12:47:07 PM
From: MJ  Respond to of 310
 
Question: What is the next step with the FDA?

I am out also--------however do wonder--------there have been other Canadian research drug stocks that have done very well.

i.e. idbe---------just taken over by Glaxo---at around $20.00.

IDBE was once a 4.00 stock

mj



To: rrufff who wrote (85)2/13/2006 12:47:07 PM
From: MJ  Respond to of 310
 
Question: What is the next step with the FDA?

I am out also--------however do wonder--------there have been other Canadian research drug stocks that have done very well.

i.e. idbe---------just taken over by Glaxo---at around $20.00.

IDBE was once a 4.00 stock

mj



To: rrufff who wrote (85)2/13/2006 12:47:08 PM
From: MJ  Read Replies (1) | Respond to of 310
 
Question: What is the next step with the FDA?

I am out also--------however do wonder--------there have been other Canadian research drug stocks that have done very well.

i.e. idbe---------just taken over by Glaxo---at around $20.00.

IDBE was once a 4.00 stock

mj


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News